Holen Sie sich die Stockscreener-App
6.64
2.60%
-0.27
Schlusskurs vom Vortag:
$6.91
Offen:
$6.67
24-Stunden-Volumen:
44,426
Relative Volume:
0.02
Marktkapitalisierung:
$2.54B
Einnahmen:
$1.21B
Nettoeinkommen (Verlust:
$-95.29M
KGV:
-25.54
EPS:
-0.26
Netto-Cashflow:
$35.06M
1W Leistung:
-8.19%
1M Leistung:
-2.89%
6M Leistung:
+26.03%
1J Leistung:
-3.17%
1-Tages-Spanne:
$6.64
$6.71
1-Wochen-Bereich:
$6.71
$7.235
52-Wochen-Spanne:
$3.74
$8.09
Lifestance Health Group Inc Stock (LFST) Company Profile
Firmenname
Lifestance Health Group Inc
Sektor
Branche
Telefon
602-767-2100
Adresse
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
Compare LFST vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFST
Lifestance Health Group Inc
|
6.64 | 2.65B | 1.21B | -95.29M | 35.06M | -0.26 |
|
HCA
Hca Healthcare Inc
|
536.88 | 120.23B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
237.00 | 20.92B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.79 | 13.08B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
208.02 | 12.20B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
184.97 | 11.64B | 16.08B | 1.20B | 1.06B | 17.82 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-07-25 | Eingeleitet | BTIG Research | Buy |
| 2025-05-27 | Hochstufung | UBS | Neutral → Buy |
| 2025-04-08 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-04-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-16 | Hochstufung | Goldman | Neutral → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-05-15 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-01-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-07 | Fortgesetzt | Jefferies | Buy |
| 2022-03-17 | Herabstufung | UBS | Buy → Neutral |
| 2021-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-06 | Eingeleitet | Goldman | Neutral |
| 2021-07-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-06 | Eingeleitet | Jefferies | Buy |
| 2021-07-06 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-07-06 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Lifestance Health Group Inc Aktie (LFST) Neueste Nachrichten
LifeStance Health Signals Profitable Growth in 2025 Call - TipRanks
Volatility Watch: Should you buy the dip on LifeStance Health Group IncDay Trade & Daily Entry Point Trade Alerts - baoquankhu1.vn
LifeStance Health Group, Inc. $LFST Shares Acquired by Vanguard Group Inc. - MarketBeat
Barclays raises Lifestance Health stock price target on growth outlook - Investing.com UK
Published on: 2026-03-06 10:46:20 - baoquankhu1.vn
LifeStance Health Group (NASDAQ:LFST) Director Darren Black Sells 4,314,939 Shares - MarketBeat
Large TPG vehicle trims LifeStance (LFST) stake with 20.7M-share sale - Stock Titan
LifeStance (LFST) Q4 2025 Earnings Call Transcript - AOL.com
LFST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
AustralianSuper Pty Ltd Makes New $17.06 Million Investment in LifeStance Health Group, Inc. $LFST - MarketBeat
LifeStance Health Group, Inc. (LFST) Stock Analysis: A 36% Potential Upside Beckons Investors - DirectorsTalk Interviews
Lifestance Health Announces Secondary Offering and Share Repurchase - TipRanks
LifeStance Health Group agrees to repurchase 7M shares, underwritten offering totals 25M shares - TradingView
[8-K] LifeStance Health Group, Inc. Reports Material Event | LFST SEC FilingForm 8-K - Stock Titan
What LifeStance Health Group (LFST)'s Profit Return, Buyback Plan, and Stock Offerings Mean For Shareholders - simplywall.st
Should LifeStance Health’s Profit Turnaround And Capital Moves Require Action From LifeStance Health Group (LFST) Investors? - Yahoo Finance
LifeStance Health Group (LFST) Profit Turn Challenges Skeptical Earnings Narratives - Sahm
Canaccord Lifts PT on LifeStance Health Group (LFST) to $10 From $9, Here's Why - Finviz
Canaccord Lifts PT on LifeStance Health Group (LFST) to $10 From $9, Here’s Why - Yahoo Finance
LifeStance (NASDAQ: LFST) selling stockholders register 25M shares; Company to repurchase 7M - Stock Titan
KeyBanc raises Lifestance Health stock price target on productivity By Investing.com - Investing.com Australia
Canaccord Genuity Group Forecasts Strong Price Appreciation for LifeStance Health Group (NASDAQ:LFST) Stock - MarketBeat
LifeStance Health Group (NASDAQ:LFST) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Key facts: LifeStance Health posts $24.1M profit; announces share offering - TradingView
6 Analysts Assess LifeStance Health Gr: What You Need To Know - Benzinga
LifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
LifeStance Health Group (NASDAQ:LFST) Sees Strong Trading Volume on Analyst Upgrade - MarketBeat
UBS Adjusts Price Target on Lifestance Health Group to $12 From $10, Maintains Buy Rating - marketscreener.com
LifeStance Health Group (NASDAQ:LFST) Price Target Raised to $9.00 - MarketBeat
KeyBanc raises Lifestance Health stock price target on productivity - Investing.com South Africa
LifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2025 Earnings Call Transcript - Insider Monkey
LifeStance stockholders plan 25M share offering By Investing.com - Investing.com India
Decoding LifeStance Health Group Inc (LFST): A Strategic SWOT In - GuruFocus
LifeStance Health Group, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:LFST) 2026-02-26 - Seeking Alpha
Earnings call transcript: LifeStance Health beats Q4 2025 expectations, stock surges - Investing.com Australia
Lifestance Health Group announces launch of secondary public offering - marketscreener.com
LifeStance Health Group (NASDAQ:LFST) Initiates Share Repurchase Program - MarketBeat
LifeStance Health Q4 2025 slides: revenue beats, EBITDA soars 49% By Investing.com - Investing.com Australia
LifeStance Health Q4 2025 Results: Profit and Revenue Beat EstimatesNews and Statistics - IndexBox
BMO Maintains Outperform on LFST LifeStance Health Group Feb 2026, PT $10 - Meyka
Lifestance Health Group Announces Launch Of Secondary Public Offering - TradingView
LifeStance stockholders plan 25M share offering - Investing.com
LifeStance CEO: Large Mental Health Company Valuations are ‘Dislocated from Reality’ - Behavioral Health Business
LifeStance Health Group Announces Launch of Secondary Public Offering - The Manila Times
Existing LifeStance investors to sell 25M shares as company buys back 7M - Stock Titan
LifeStance Health (NASDAQ: LFST) outlines 2025 scale, payor mix and risks - Stock Titan
LifeStance Health Group Q4 Earnings Call Highlights - MarketBeat
LFST SEC FilingsLifestance Health Group, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Key facts: LifeStance Health reports 14% revenue growth; Burdick named Non-Executive Chairman - TradingView
LifeStance Health Group (NASDAQ:LFST) Shares Gap UpStill a Buy? - MarketBeat
LifeStance Health Group Q4 2025 Earnings Call Transcript - MarketBeat
Finanzdaten der Lifestance Health Group Inc-Aktie (LFST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifestance Health Group Inc-Aktie (LFST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BLACK DARREN M. | Director |
Mar 02 '26 |
Sale |
7.01 |
4,314,939 |
30,247,722 |
29,209,776 |
| Bessler Robert | Director |
Dec 19 '25 |
Sale |
7.04 |
119,942 |
844,392 |
1,318,983 |
| Bessler Robert | Director |
Dec 22 '25 |
Sale |
7.04 |
1,701 |
11,975 |
1,318,133 |
0.51%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):